Amgen Inc.
AMGN
Cena:
$ 339.30
+1.88 (0.56%)
Valuace
33
Růst
40
Zdraví
79
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
13-02-2026
THOUSAND OAKS, CALIF., FEB. 13, 2026 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) WILL PRESENT AT CITI'S 2026...
Více zde
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
03-02-2026
THOUSAND OAKS, CALIF., FEB. 3, 2026 /PRNEWSWIRE/ -- AMGEN (NASDAQ: AMGN) TODAY ANNOUNCED FINANCIAL R...
Více zde
AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
28-01-2026
THOUSAND OAKS, CALIF., JAN. 28, 2026 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED THAT IT WIL...
Více zde
NONPROFIT HEALTH SERVICES ORGANIZATION FILES LAWSUIT AGAINST FORTUNE 500 PHARMACEUTICAL COMPANY OVER PRESCRIPTION DRUG ACCESS
20-01-2026
LAS VEGAS--(BUSINESS WIRE)--SAGEBRUSH HEALTH SERVICES, A NONPROFIT ORGANIZATION SERVING OVER 10,000 ...
Více zde
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
07-01-2026
THOUSAND OAKS, CALIF., JAN. 7, 2026 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) WILL PRESENT AT THE 2026 J.P...
Více zde
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
06-01-2026
ACQUISITION ADDS DIFFERENTIATED INVESTIGATIONAL MOLECULE DESIGNED TO TREAT ACUTE MYELOID LEUKEMIA TH...
Více zde
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
19-12-2025
UNDERSCORES LONG-STANDING COMMITMENT TO INVESTING IN INNOVATION AND U.S. MANUFACTURING THOUSAND OAKS...
Více zde
FDA APPROVES AMGEN'S UPLIZNA® (INEBILIZUMAB-CDON) FOR GENERALIZED MYASTHENIA GRAVIS (GMG), EXPANDING TREATMENT OPTIONS FOR PATIENTS LIVING WITH AUTOIMMUNE NEUROMUSCULAR DISEASE
12-12-2025
NEW YORK, DEC. 12, 2025 (GLOBE NEWSWIRE) -- THE MUSCULAR DYSTROPHY ASSOCIATION (MDA) RECOGNIZES THE ...
Více zde
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
11-12-2025
UPLIZNA OFFERS GMG PATIENTS DEEP AND DURABLE SYMPTOM CONTROL AND TWICE-YEARLY DOSING* FIRST AND ONLY...
Více zde
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND
09-12-2025
THOUSAND OAKS, CALIF. , DEC. 9, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED THAT ITS BO...
Více zde
AMGEN TO PRESENT AT CITI'S 2025 GLOBAL HEALTHCARE CONFERENCE
24-11-2025
THOUSAND OAKS, CALIF. , NOV. 24, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) WILL PRESENT AT CITI'S 20...
Více zde
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
19-11-2025
GLOBAL CONFIRMATORY PHASE 3 DELLPHI-304 TRIAL SHOWED IMDELLTRA REDUCED RISK OF DEATH BY 40% COMPARED...
Více zde
AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
08-11-2025
STUDY ALSO SHOWS 36% REDUCTION IN RISK OF HEART ATTACK REPATHA IS THE FIRST AND ONLY PCSK9 INHIBIT...
Více zde
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
04-11-2025
THOUSAND OAKS, CALIF. , NOV. 4, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED FINANCIAL R...
Více zde
AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND
31-10-2025
THOUSAND OAKS, CALIF. , OCT. 31, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED THAT ITS ...
Více zde
AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
31-10-2025
REPATHA VESALIUS-CV TRIAL MET DUAL PRIMARY ENDPOINTS DEMONSTRATING REDUCTION IN CV EVENTS IN HIGH-RI...
Více zde
AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS
29-10-2025
THOUSAND OAKS, CALIF. , OCT. 29, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED THAT IT W...
Více zde
HALPER SADEH LLC ENCOURAGES AMGEN INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
22-10-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER C...
Více zde
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
17-10-2025
APPROVAL BROADENS INDICATION FOR TEZSPIRE TO A SECOND DISEASE CHARACTERIZED BY EPITHELIAL-DRIVEN INF...
Více zde
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
06-10-2025
ELIGIBLE PATIENTS CAN ACCESS REPATHA AT NEARLY 60% DISCOUNT FROM THE LIST PRICE THOUSAND OAKS, CAL...
Více zde
LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
02-10-2025
ADDING REPATHA TO STANDARD THERAPY OF STATINS OR OTHER LDL-C LOWERING TREATMENTS SIGNIFICANTLY REDUC...
Více zde
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
26-09-2025
THOUSAND OAKS, CALIF. , SEPT. 26, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ: AMGN) TODAY ANNOUNCED A $650 M...
Více zde
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
09-09-2025
THOUSAND OAKS, CALIF. AND TOKYO, SEPT. 09, 2025 (GLOBE NEWSWIRE) -- AMGEN (NASDAQ:AMGN) AND KYOWA KI...
Více zde
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
08-09-2025
THOUSAND OAKS, CALIF. AND TOKYO , SEPT....
Více zde
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
04-09-2025
THOUSAND OAKS, CALIF. , SEPT. 4, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) WILL PRESENT AT THE MORGA...
Více zde
AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS
02-09-2025
RESEARCH AND DEVELOPMENT INFRASTRUCTURE INVESTMENT EXPECTED TO CREATE HUNDREDS OF U.S. JOBS THOUS...
Více zde
AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE
29-08-2025
THOUSAND OAKS, CALIF. , AUG. 29, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) WILL PRESENT AT THE 2025 ...
Více zde
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
25-08-2025
THOUSAND OAKS, CALIF. , AUG. 25, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED THAT THE U...
Více zde
ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN AMGEN'S IMDELLTRA FOR UP TO $950 MILLION
25-08-2025
NEW YORK, AUG. 25, 2025 (GLOBE NEWSWIRE) -- ROYALTY PHARMA PLC (NASDAQ: RPRX) TODAY ANNOUNCED THAT I...
Více zde
AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
05-08-2025
THOUSAND OAKS, CALIF. , AUG. 5, 2025 /PRNEWSWIRE/ -- AMGEN (NASDAQ:AMGN) TODAY ANNOUNCED FINANCIAL R...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-02-13 00:00:00 | 10-K | Stáhnout | |
| 2026-02-03 00:00:00 | 8-K | Stáhnout | |
| 2026-01-30 00:00:00 | 8-K | Stáhnout | |
| 2025-11-05 00:00:00 | 10-Q | Stáhnout | |
| 2025-11-04 00:00:00 | 8-K | Stáhnout | |
| 2025-08-06 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-06 00:00:00 | 10-Q | Stáhnout | |
| 2025-08-05 01:00:00 | 8-K | Stáhnout | |
| 2025-08-05 00:00:00 | 8-K | Stáhnout | |
| 2025-05-27 01:00:00 | 8-K | Stáhnout | |
| 2025-05-27 00:00:00 | 8-K | Stáhnout | |
| 2025-05-02 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-02 00:00:00 | 10-Q | Stáhnout | |
| 2025-05-01 01:00:00 | 8-K | Stáhnout | |
| 2025-05-01 00:00:00 | 8-K | Stáhnout | |
| 2025-02-14 00:00:00 | 10-K | Stáhnout | |
| 2025-02-13 23:00:00 | 10-K | Stáhnout | |
| 2025-02-04 00:00:00 | 8-K | Stáhnout | |
| 2025-02-03 23:00:00 | 8-K | Stáhnout | |
| 2024-10-31 00:00:00 | 10-Q | Stáhnout | |
| 2024-10-30 23:00:00 | 10-Q | Stáhnout | |
| 2024-10-30 00:00:00 | 8-K | Stáhnout | |
| 2024-10-29 23:00:00 | 8-K | Stáhnout | |
| 2024-08-07 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-07 00:00:00 | 10-Q | Stáhnout | |
| 2024-08-06 01:00:00 | 8-K | Stáhnout | |
| 2024-08-06 00:00:00 | 8-K | Stáhnout | |
| 2024-06-03 01:00:00 | 8-K | Stáhnout | |
| 2024-06-03 00:00:00 | 8-K | Stáhnout | |
| 2024-05-03 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-03 00:00:00 | 10-Q | Stáhnout | |
| 2024-05-02 01:00:00 | 8-K | Stáhnout | |
| 2024-05-02 00:00:00 | 8-K | Stáhnout | |
| 2024-02-14 00:00:00 | 10-K | Stáhnout | |
| 2024-02-13 23:00:00 | 10-K | Stáhnout | |
| 2024-02-06 00:00:00 | 8-K | Stáhnout | |
| 2024-02-05 23:00:00 | 8-K | Stáhnout | |
| 2023-12-14 00:00:00 | 8-K | Stáhnout | |
| 2023-12-13 23:00:00 | 8-K | Stáhnout | |
| 2023-10-31 00:00:00 | 8-K | Stáhnout | |
| 2023-10-31 00:00:00 | 10-Q | Stáhnout | |
| 2023-10-30 23:00:00 | 8-K | Stáhnout | |
| 2023-10-30 23:00:00 | 10-Q | Stáhnout | |
| 2023-10-06 01:00:00 | 8-K | Stáhnout | |
| 2023-10-06 00:00:00 | 8-K | Stáhnout | |
| 2023-10-05 01:00:00 | 8-K | Stáhnout | |
| 2023-10-05 00:00:00 | 8-K | Stáhnout | |
| 2023-09-12 01:00:00 | 8-K | Stáhnout | |
| 2023-09-12 00:00:00 | 8-K | Stáhnout | |
| 2023-09-05 01:00:00 | 8-K | Stáhnout | |
| 2023-09-05 00:00:00 | 8-K | Stáhnout | |
| 2023-09-01 01:00:00 | 8-K | Stáhnout | |
| 2023-09-01 00:00:00 | 8-K | Stáhnout | |
| 2023-08-04 01:00:00 | 8-K | Stáhnout | |
| 2023-08-04 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-04 00:00:00 | 8-K | Stáhnout | |
| 2023-08-04 00:00:00 | 10-Q | Stáhnout | |
| 2023-08-03 01:00:00 | 8-K | Stáhnout | |
| 2023-08-03 00:00:00 | 8-K | Stáhnout | |
| 2023-06-05 01:00:00 | 8-K | Stáhnout | |
| 2023-06-05 00:00:00 | 8-K | Stáhnout | |
| 2023-05-22 01:00:00 | 8-K | Stáhnout | |
| 2023-05-22 00:00:00 | 8-K | Stáhnout | |
| 2023-05-18 01:00:00 | 8-K | Stáhnout | |
| 2023-05-18 00:00:00 | 8-K | Stáhnout | |
| 2023-05-16 01:00:00 | 8-K | Stáhnout | |
| 2023-05-16 00:00:00 | 8-K | Stáhnout | |
| 2023-04-28 01:00:00 | 10-Q | Stáhnout | |
| 2023-04-28 00:00:00 | 10-Q | Stáhnout | |
| 2023-04-27 01:00:00 | 8-K | Stáhnout | |
| 2023-04-27 00:00:00 | 8-K | Stáhnout | |
| 2023-03-09 00:00:00 | 8-K | Stáhnout | |
| 2023-03-08 23:00:00 | 8-K | Stáhnout | |
| 2023-03-02 00:00:00 | 8-K | Stáhnout | |
| 2023-03-01 23:00:00 | 8-K | Stáhnout | |
| 2023-02-16 00:00:00 | 8-K | Stáhnout | |
| 2023-02-15 23:00:00 | 8-K | Stáhnout | |
| 2023-02-09 00:00:00 | 10-K | Stáhnout | |
| 2023-02-08 23:00:00 | 10-K | Stáhnout | |
| 2023-01-31 00:00:00 | 8-K | Stáhnout | |
| 2023-01-30 23:00:00 | 8-K | Stáhnout | |
| 2022-12-22 00:00:00 | 8-K | Stáhnout | |
| 2022-12-21 23:00:00 | 8-K | Stáhnout | |
| 2022-12-12 00:00:00 | 8-K | Stáhnout | |
| 2022-12-11 23:00:00 | 8-K | Stáhnout | |
| 2022-12-02 00:00:00 | 8-K | Stáhnout | |
| 2022-12-01 23:00:00 | 8-K | Stáhnout | |
| 2022-11-04 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-03 23:00:00 | 10-Q | Stáhnout | |
| 2022-11-03 00:00:00 | 8-K | Stáhnout | |
| 2022-11-02 23:00:00 | 8-K | Stáhnout | |
| 2022-10-20 01:00:00 | 8-K | Stáhnout | |
| 2022-10-20 00:00:00 | 8-K | Stáhnout | |
| 2022-08-18 01:00:00 | 8-K | Stáhnout | |
| 2022-08-18 00:00:00 | 8-K | Stáhnout | |
| 2022-08-05 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-05 00:00:00 | 10-Q | Stáhnout | |
| 2022-08-04 01:00:00 | 8-K | Stáhnout | |
| 2022-08-04 00:00:00 | 8-K | Stáhnout | |
| 2022-08-03 01:00:00 | 8-K | Stáhnout | |
| 2022-08-03 00:00:00 | 8-K | Stáhnout | |
| 2022-05-18 01:00:00 | 8-K | Stáhnout | |
| 2022-05-18 00:00:00 | 8-K | Stáhnout | |
| 2022-04-28 01:00:00 | 10-Q | Stáhnout | |
| 2022-04-28 00:00:00 | 10-Q | Stáhnout | |
| 2022-04-27 01:00:00 | 8-K | Stáhnout | |
| 2022-04-27 00:00:00 | 8-K | Stáhnout | |
| 2022-02-25 00:00:00 | 8-K | Stáhnout | |
| 2022-02-24 23:00:00 | 8-K | Stáhnout | |
| 2022-02-22 00:00:00 | 8-K | Stáhnout | |
| 2022-02-21 23:00:00 | 8-K | Stáhnout | |
| 2022-02-16 00:00:00 | 10-K | Stáhnout | |
| 2022-02-15 23:00:00 | 10-K | Stáhnout | |
| 2022-02-07 00:00:00 | 8-K | Stáhnout | |
| 2022-02-06 23:00:00 | 8-K | Stáhnout | |
| 2022-01-31 00:00:00 | 8-K | Stáhnout | |
| 2022-01-30 23:00:00 | 8-K | Stáhnout | |
| 2021-11-03 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-02 23:00:00 | 10-Q | Stáhnout | |
| 2021-11-02 00:00:00 | 8-K | Stáhnout | |
| 2021-11-01 23:00:00 | 8-K | Stáhnout | |
| 2021-08-09 01:00:00 | 8-K | Stáhnout | |
| 2021-08-09 00:00:00 | 8-K | Stáhnout | |
| 2021-08-04 01:00:00 | 10-Q | Stáhnout | |
| 2021-08-04 00:00:00 | 10-Q | Stáhnout | |
| 2021-08-03 01:00:00 | 8-K | Stáhnout | |
| 2021-08-03 00:00:00 | 8-K | Stáhnout | |
| 2021-07-30 01:00:00 | 8-K | Stáhnout | |
| 2021-07-30 00:00:00 | 8-K | Stáhnout | |
| 2021-07-27 01:00:00 | 8-K | Stáhnout | |
| 2021-07-27 00:00:00 | 8-K | Stáhnout | |
| 2021-06-01 01:00:00 | 8-K | Stáhnout | |
| 2021-06-01 00:00:00 | 8-K | Stáhnout | |
| 2021-05-19 01:00:00 | 8-K | Stáhnout | |
| 2021-05-19 00:00:00 | 8-K | Stáhnout | |
| 2021-04-28 01:00:00 | 10-Q | Stáhnout | |
| 2021-04-28 00:00:00 | 10-Q | Stáhnout | |
| 2021-04-27 01:00:00 | 8-K | Stáhnout | |
| 2021-04-27 00:00:00 | 8-K | Stáhnout | |
| 2021-04-16 01:00:00 | 8-K | Stáhnout | |
| 2021-04-16 00:00:00 | 8-K | Stáhnout | |
| 2021-03-04 00:00:00 | 8-K | Stáhnout | |
| 2021-03-03 23:00:00 | 8-K | Stáhnout | |
| 2021-02-09 00:00:00 | 10-K | Stáhnout | |
| 2021-02-08 23:00:00 | 10-K | Stáhnout | |
| 2021-02-02 00:00:00 | 8-K | Stáhnout | |
| 2021-02-01 23:00:00 | 8-K | Stáhnout | |
| 2020-10-29 00:00:00 | 10-Q | Stáhnout | |
| 2020-10-28 23:00:00 | 10-Q | Stáhnout | |
| 2020-10-28 00:00:00 | 8-K | Stáhnout | |
| 2020-10-27 23:00:00 | 8-K | Stáhnout | |
| 2020-08-18 01:00:00 | 8-K | Stáhnout | |
| 2020-08-18 00:00:00 | 8-K | Stáhnout | |
| 2020-08-14 01:00:00 | 8-K | Stáhnout | |
| 2020-08-14 00:00:00 | 8-K | Stáhnout | |
| 2020-07-30 01:00:00 | 8-K | Stáhnout | |
| 2020-07-30 00:00:00 | 8-K | Stáhnout | |
| 2020-07-29 01:00:00 | 10-Q | Stáhnout | |
| 2020-07-29 00:00:00 | 10-Q | Stáhnout | |
| 2020-07-28 01:00:00 | 8-K | Stáhnout | |
| 2020-07-28 00:00:00 | 8-K | Stáhnout | |
| 2020-07-23 01:00:00 | 8-K | Stáhnout | |
| 2020-07-23 00:00:00 | 8-K | Stáhnout | |
| 2020-05-20 01:00:00 | 8-K | Stáhnout | |
| 2020-05-20 00:00:00 | 8-K | Stáhnout | |
| 2020-05-06 01:00:00 | 8-K | Stáhnout | |
| 2020-05-06 00:00:00 | 8-K | Stáhnout | |
| 2020-05-01 01:00:00 | 10-Q | Stáhnout | |
| 2020-05-01 00:00:00 | 10-Q | Stáhnout | |
| 2020-04-30 01:00:00 | 8-K | Stáhnout | |
| 2020-04-30 00:00:00 | 8-K | Stáhnout | |
| 2020-03-31 01:00:00 | 8-K | Stáhnout | |
| 2020-03-31 00:00:00 | 8-K | Stáhnout | |
| 2020-02-21 00:00:00 | 8-K | Stáhnout | |
| 2020-02-20 23:00:00 | 8-K | Stáhnout | |
| 2020-02-12 00:00:00 | 10-K | Stáhnout | |
| 2020-02-11 23:00:00 | 10-K | Stáhnout | |
| 2020-01-30 00:00:00 | 8-K | Stáhnout | |
| 2020-01-29 23:00:00 | 8-K | Stáhnout | |
| 2020-01-02 00:00:00 | 8-K | Stáhnout | |
| 2020-01-01 23:00:00 | 8-K | Stáhnout | |
| 2019-12-12 00:00:00 | 8-K | Stáhnout | |
| 2019-12-11 23:00:00 | 8-K | Stáhnout | |
| 2019-11-21 00:00:00 | 8-K | Stáhnout | |
| 2019-11-20 23:00:00 | 8-K | Stáhnout | |
| 2019-10-31 00:00:00 | 8-K | Stáhnout | |
| 2019-10-30 23:00:00 | 8-K | Stáhnout | |
| 2019-10-30 00:00:00 | 10-Q | Stáhnout | |
| 2019-10-29 23:00:00 | 10-Q | Stáhnout | |
| 2019-10-29 00:00:00 | 8-K | Stáhnout | |
| 2019-10-28 23:00:00 | 8-K | Stáhnout | |
| 2019-10-23 01:00:00 | 8-K | Stáhnout | |
| 2019-10-23 00:00:00 | 8-K | Stáhnout | |
| 2019-10-18 01:00:00 | 8-K | Stáhnout | |
| 2019-10-18 00:00:00 | 8-K | Stáhnout | |
| 2019-08-26 01:00:00 | 8-K | Stáhnout | |
| 2019-08-26 00:00:00 | 8-K | Stáhnout | |
| 2019-07-31 01:00:00 | 10-Q | Stáhnout | |
| 2019-07-31 00:00:00 | 10-Q | Stáhnout | |
| 2019-07-30 01:00:00 | 8-K | Stáhnout | |
| 2019-07-30 00:00:00 | 8-K | Stáhnout | |
| 2019-05-21 01:00:00 | 8-K | Stáhnout | |
| 2019-05-21 00:00:00 | 8-K | Stáhnout | |
| 2019-05-01 01:00:00 | 10-Q | Stáhnout | |
| 2019-05-01 00:00:00 | 10-Q | Stáhnout | |
| 2019-04-30 01:00:00 | 8-K | Stáhnout | |
| 2019-04-30 00:00:00 | 8-K | Stáhnout | |
| 2019-02-13 00:00:00 | 10-K | Stáhnout | |
| 2019-02-12 23:00:00 | 10-K | Stáhnout | |
| 2019-01-29 00:00:00 | 8-K | Stáhnout | |
| 2019-01-28 23:00:00 | 8-K | Stáhnout | |
| 2018-10-31 00:00:00 | 10-Q | Stáhnout | |
| 2018-10-30 23:00:00 | 10-Q | Stáhnout | |
| 2018-10-30 00:00:00 | 8-K | Stáhnout | |
| 2018-10-29 23:00:00 | 8-K | Stáhnout | |
| 2018-07-27 01:00:00 | 10-Q | Stáhnout | |
| 2018-07-27 00:00:00 | 10-Q | Stáhnout | |
| 2018-07-26 01:00:00 | 8-K | Stáhnout | |
| 2018-07-26 00:00:00 | 8-K | Stáhnout | |
| 2018-05-22 01:00:00 | 8-K | Stáhnout | |
| 2018-05-22 00:00:00 | 8-K | Stáhnout | |
| 2018-04-25 01:00:00 | 10-Q | Stáhnout | |
| 2018-04-25 00:00:00 | 10-Q | Stáhnout | |
| 2018-04-24 01:00:00 | 8-K | Stáhnout | |
| 2018-04-24 00:00:00 | 8-K | Stáhnout | |
| 2018-02-13 00:00:00 | 10-K | Stáhnout | |
| 2018-02-12 23:00:00 | 10-K | Stáhnout | |
| 2018-02-05 00:00:00 | 8-K | Stáhnout | |
| 2018-02-04 23:00:00 | 8-K | Stáhnout | |
| 2018-02-01 00:00:00 | 8-K | Stáhnout | |
| 2018-01-31 23:00:00 | 8-K | Stáhnout | |
| 2017-12-22 00:00:00 | 8-K | Stáhnout | |
| 2017-12-21 23:00:00 | 8-K | Stáhnout | |
| 2017-11-02 00:00:00 | 8-K | Stáhnout | |
| 2017-11-01 23:00:00 | 8-K | Stáhnout | |
| 2017-10-31 00:00:00 | 8-K | Stáhnout | |
| 2017-10-30 23:00:00 | 8-K | Stáhnout | |
| 2017-10-26 01:00:00 | 10-Q | Stáhnout | |
| 2017-10-26 00:00:00 | 10-Q | Stáhnout | |
| 2017-10-25 01:00:00 | 8-K | Stáhnout | |
| 2017-10-25 00:00:00 | 8-K | Stáhnout | |
| 2017-10-24 01:00:00 | 8-K | Stáhnout | |
| 2017-10-24 00:00:00 | 8-K | Stáhnout | |
| 2017-07-26 01:00:00 | 10-Q | Stáhnout | |
| 2017-07-26 00:00:00 | 10-Q | Stáhnout | |
| 2017-07-25 01:00:00 | 8-K | Stáhnout | |
| 2017-07-25 00:00:00 | 8-K | Stáhnout | |
| 2017-05-22 01:00:00 | 8-K | Stáhnout | |
| 2017-05-22 00:00:00 | 8-K | Stáhnout | |
| 2017-05-11 01:00:00 | 8-K | Stáhnout | |
| 2017-05-11 00:00:00 | 8-K | Stáhnout | |
| 2017-04-27 01:00:00 | 10-Q | Stáhnout | |
| 2017-04-27 00:00:00 | 10-Q | Stáhnout | |
| 2017-04-26 01:00:00 | 8-K | Stáhnout | |
| 2017-04-26 00:00:00 | 8-K | Stáhnout | |
| 2017-04-24 01:00:00 | 8-K | Stáhnout | |
| 2017-04-24 00:00:00 | 8-K | Stáhnout | |
| 2017-02-14 00:00:00 | 10-K | Stáhnout | |
| 2017-02-13 23:00:00 | 10-K | Stáhnout | |
| 2017-02-03 00:00:00 | 8-K | Stáhnout | |
| 2017-02-02 23:00:00 | 8-K | Stáhnout | |
| 2017-02-02 00:00:00 | 8-K | Stáhnout | |
| 2017-02-01 23:00:00 | 8-K | Stáhnout | |
| 2017-01-09 00:00:00 | 8-K | Stáhnout | |
| 2017-01-08 23:00:00 | 8-K | Stáhnout | |
| 2016-10-31 00:00:00 | 8-K | Stáhnout | |
| 2016-10-30 23:00:00 | 8-K | Stáhnout | |
| 2016-10-28 01:00:00 | 10-Q | Stáhnout | |
| 2016-10-28 00:00:00 | 10-Q | Stáhnout | |
| 2016-10-27 01:00:00 | 8-K | Stáhnout | |
| 2016-10-27 00:00:00 | 8-K | Stáhnout | |
| 2016-10-14 01:00:00 | 8-K | Stáhnout | |
| 2016-10-14 00:00:00 | 8-K | Stáhnout | |
| 2016-08-19 01:00:00 | 8-K | Stáhnout | |
| 2016-08-19 00:00:00 | 8-K | Stáhnout | |
| 2016-07-29 01:00:00 | 10-Q | Stáhnout | |
| 2016-07-29 00:00:00 | 10-Q | Stáhnout | |
| 2016-07-27 01:00:00 | 8-K | Stáhnout | |
| 2016-07-27 00:00:00 | 8-K | Stáhnout | |
| 2016-06-14 01:00:00 | 8-K | Stáhnout | |
| 2016-06-14 00:00:00 | 8-K | Stáhnout | |
| 2016-06-10 01:00:00 | 8-K | Stáhnout | |
| 2016-06-10 00:00:00 | 8-K | Stáhnout | |
| 2016-05-26 01:00:00 | 8-K | Stáhnout | |
| 2016-05-26 00:00:00 | 8-K | Stáhnout | |
| 2016-05-20 01:00:00 | 8-K | Stáhnout | |
| 2016-05-20 00:00:00 | 8-K | Stáhnout | |
| 2016-05-13 01:00:00 | 8-K | Stáhnout | |
| 2016-05-13 00:00:00 | 8-K | Stáhnout | |
| 2016-05-02 00:00:00 | 10-Q | Stáhnout | |
| 2016-04-28 00:00:00 | 8-K | Stáhnout |
